American Journal of Kidney Diseases
Volume 53, Issue 3, Supplement 3 , Pages S4-S16 , March 2009

Conceptual Model of CKD: Applications and Implications

  • Andrew S. Levey, MD

      Affiliations

    • Division of Nephrology, Tufts Medical Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Andrew S. Levey, MD, Division of Nephrology, Tufts Medical Center, 800 Washington St, Box 391, Boston, MA 02111
    • ,
  • Lesley A. Stevens, MD, MS

      Affiliations

    • Division of Nephrology, Tufts Medical Center, Boston, MA
    • ,
  • Josef Coresh, MD, PhD

      Affiliations

    • Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, MD

References 

  1. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  2. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
  3. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100
  4. Levey A, Schoolwerth AC, Burrows NR, Williams DE, Stith KR, McClellan W. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: Report of an expert panel convened by the Centers of Disease Control and Prevention. Am J Kidney Disease. 2009;53:522–535
  5. Committee on Chronic Kidney Disease. Report of the Committee on Chronic Kidney Disease. Washington, DC: US Bureau of the Budget; 1967;
  6. Retting R. Origins of the Medicare kidney disease entitlement: The Social Security Amendments of 1972. In:  Hanna K editors. Biomedical Politics. Washington DC: National Academy; 1991;p. 176–208
  7. Brenner BM, Meyer TW, Hostetter TH. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med. 1982;307:652–659
  8. Pereira BJG. Optimization of pre-ESRD care: The key to improved dialysis outcomes. Kidney Int. 2000;57:351–365
  9. Levey A, Beto J, Coronado B, et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? (National Kidney Foundation Task Force on Cardiovascular Disease). Am J Kidney Dis. 1998;32:853–906
  10. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis. 2007;50:169–180
  11. Stevens LA, Levey AS. Current status and future perspectives for CKD testing. Am J Kidney Dis. 2009;53(suppl 3):S17–S26
  12. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Hypertension and Antihypertensive Agents in Chronic Kidney Disease. Am J Kidney Dis. 2004;43(suppl 1):S1–S290
  13. US Renal Data System. USRDS 2007 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007;http://www.usrds.org/adr.htmAccessed June 26, 2007
  14. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006;47(suppl 3):S1–S146
  15. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of hemoglobin target. Am J Kidney Dis. 2007;50:471–530
  16. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis. 2000;35(suppl 2):S1–S140
  17. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003;42(suppl 3):S1–S202
  18. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  19. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003;289:2560–2572
  20. American Diabetes Association. Standards of Medical Care in Diabetes—2006. Diabetes Care. 2006;29(suppl 1):S1–S71
  21. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. Am J Kidney Dis. 2005;45(suppl 4):S1–S153
  22. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Management of Dyslipidemias in Chronic Kidney Disease. Am J Kidney Dis. 2003;41(suppl 3):S1–S92
  23. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(suppl 2):S1–S180
  24. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med. 2006;134:629–636
  25. Solomon SD, Rice MM, Jablonski KA, et al. Renal function and effectiveness of angiotensin-converting enzyme inhibitor therapy in patients with chronic stable coronary disease in the Prevention of Events with ACE inhibition (PEACE) trial. Circulation. 2006;114:26–31
  26. Tonelli M, Moye L, Sacks FM, Kiberd B, Curhan G. Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med. 2003;138:98–104
  27. Elsayed EF, Tighiouart H, Griffith J, et al. Cardiovascular disease and subsequent kidney disease. Arch Intern Med. 2007;167:1130–1136
  28. Menon V, Sarnak MJ, Levey AS. Risk factors and kidney disease. In:  Brenner B editors. The Kidney. (ed 8). Philadelphia: Saunders Elsevier; 2007;p. 633–653Chap 18
  29. AskOxford: Compact Oxford English Dictionary entry for “disease”. Available at http://www.askoxford.com/concise_oed/disease?view=uk. Accessed December 3, 2008
  30. Coresh J, Selvin E, Stevens L, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  31. Keith D, Nicholls G, Guillion C, Brown J, Smith D. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
  32. Smith D, Gullion G, Nichols G, Keith D, Brown J. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol. 2004;15:1300–1306
  33. Levey AS, Coresh J. Should the K/DOQI definition of chronic kidney disease be changed?. Am J Kidney Dis. 2003;42:626–630
  34. O'Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18:2758–2765
  35. Murray P, Devarajan P, Levey A, et al. A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol. 2007;3:864–868
  36. Levin A, Warnock DG, Mehta RL, et al. Improving outcomes from acute kidney injury: Report of an initiative. Am J Kidney Dis. 2007;50:1–4
  37. Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest. 2006;116:288–296
  38. Bello AK, de Zeeuw D, El Nahas M, et al. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant. 2007;22:1619–1627
  39. Eknoyan G, Hostetter T, Bakris G, et al. Proteinuria and other markers of chronic kidney disease: A position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Am J Kidney Dis. 2003;42:617–622
  40. Mann J, Gerstein H, Yi Q, et al. Development of renal disease in people at high cardiovascular risk: Results of the HOPE randomized study. J Am Soc Nephrol. 2003;14:641–647
  41. Kramer H, Nguyen Q, Curhan G, Hsu C. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289:3273–3277
  42. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III. Kidney Int. 2002;61:2165–2175
  43. Hillege H, Fidler V, Diercks G, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–1782
  44. Xu J, Lee ET, Devereux RB, et al. A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: The Strong Heart Study. Am J Kidney Dis. 2008;51:415–424
  45. Wesson L. Physiology of the Human Kidney. New York: Grune & Stratton; 1969;
  46. Silva FG. The aging kidney: A review—Part I. Int Urol Nephrol. 2005;37:185–205
  47. Silva FG. The aging kidney: A review—Part II. Int Urol Nephrol. 2005;37:419–432
  48. Stevens LA, Levey AS. Chronic kidney disease in the elderly—How to assess risk?. N Engl J Med. 2005;352:2122–2124
  49. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–2060
  50. Go A, Chertow G, Dongjie F, McCulloch C, Hsu CY. Chronic kidney disease and risks of death, cardiovascular events and hospitalizations. N Engl J Med. 2004;351:1296–1305
  51. Steinman M, Landefeld C, Rosenthal G, Berthenthal D, Sen S, Kabol P. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54:16–23
  52. Fried L, Ferrucci L, Darer J, Williamson J, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol Series A Biol Sci Med Sci. 2004;59:255–263
  53. Astor B, Hallan S, Miller E, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008;167:1226–1234
  54. Hallan S, Astor B, Romundstad S, Aasarod K, Kvenild K, Coresh J. Association of kidney function and albuminuria with cardiovascular mortality in older compared to younger individuals: The HUNT II Study. Arch Intern Med. 2007;167:2490–2496

PII: S0272-6386(08)01718-6

doi: 10.1053/j.ajkd.2008.07.048

American Journal of Kidney Diseases
Volume 53, Issue 3, Supplement 3 , Pages S4-S16 , March 2009

Article Tools

* Image Usage & Resolution